AI SMILE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

AI SMILE Trademark

Serial Number: 79351421 • Registration: 7204108

AI SMILE is a trademark filed by SHANGHAI WEIYUN INDUSTRIAL GROUP CO., LTD. on June 16, 2022. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SHANGHAI WEIYUN INDUSTRIAL GROUP CO., LTD.

Room 801, 8th Floor, Building 1,

Entity Type: 16

Trademark Details

Filing Date

June 16, 2022

Registration Date

October 31, 2023

Published for Opposition

August 15, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 26, 2024 FINV
GENERIC MADRID TRANSACTION SENT TO IB
Feb 5, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 5, 2024 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 31, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 31, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 31, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Aug 21, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 15, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 15, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 2, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 2, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 26, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 7, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 3, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 3, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 3, 2023 TROA
REFUSAL PROCESSED BY IB
Jun 12, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 19, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 19, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 30, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 29, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 29, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 18, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 13, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 13, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 29, 2022 REPR